Article

Goblet cell dysfunction may occur after LASIK

Lisbon, Portugal - Dry eye syndrome after LASIK may be the result of goblet cell dysfunction. Extended application of artificial tears may be warranted to facilitate the return to normal function, Ahmed Galal, MD, PhD, said Tuesday at the European Society of Cataract and Refractive Surgeons meeting.

Lisbon, Portugal - Dry eye syndrome after LASIK may be the result of goblet cell dysfunction. Extended application of artificial tears may be warranted to facilitate the return to normal function, Ahmed Galal, MD, PhD, said Tuesday at the European Society of Cataract and Refractive Surgeons meeting.

“After LASIK, surgeons instruct patients to use artificial tears for 1 month and then longer as needed. However, dry eye lasts longer and may require longer treatment with artificial tears,” Dr. Galal stated. He is from VISSUM Instituto Oftalmologico de Alicante and Miguel Hernandez University, Alicante, Spain.

In a prospective controlled, noncomparative study, Dr. Galal and colleagues evaluated 22 eyes of 12 patients who had undergone LASIK for myopia. The investigators performed conjunctival impression cytology in all eyes in the superior bulbar conjunctiva, the inferior temporal conjunctiva, and at the perilimbal conjunctiva using cellulose acetate filter paper before LASIK and then 1 week and 1 and months postoperatively.

Dr. Galal reported that the goblet cell density decreased from 485/mm² to 430/mm² 3 months after LASIK. All samples taken postoperatively showed a significant decrease in the goblet cell density.

“When we compared the preoperative impression cytology with the postoperative impression cytology, there was a decrease in the goblet cell density. The mean decrease in the number of goblet cells per mm² was a mean of 63.5%. The goblet cell density decreased up to 6 months after LASIK. Application of artificial tears from 6 months to up to 1 year after LASIK may be needed,” Dr. Galal concluded.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.